v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   58,310,644      
Beginning balance at Dec. 31, 2024 $ 538,546 $ 58 $ 712,706 $ 74 $ (174,292)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from the exercise of stock options and settlement of equity awards (in shares)   623,338      
Issuance of common stock from the exercise of stock options and settlement of equity awards (915) $ 1 (916)    
Stock-based compensation expense 2,971   2,971    
Net loss (29,494)       (29,494)
Other comprehensive income (loss), net of tax 309     309  
Ending balance (in shares) at Mar. 31, 2025   58,933,982      
Ending balance at Mar. 31, 2025 511,417 $ 59 714,761 383 (203,786)
Beginning balance (in shares) at Dec. 31, 2024   58,310,644      
Beginning balance at Dec. 31, 2024 538,546 $ 58 712,706 74 (174,292)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (56,701)        
Other comprehensive income (loss), net of tax 322        
Ending balance (in shares) at Jun. 30, 2025   59,080,630      
Ending balance at Jun. 30, 2025 486,329 $ 59 716,867 396 (230,993)
Beginning balance (in shares) at Mar. 31, 2025   58,933,982      
Beginning balance at Mar. 31, 2025 511,417 $ 59 714,761 383 (203,786)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from the exercise of stock options and settlement of equity awards (in shares)   146,648      
Stock-based compensation expense 2,106   2,106    
Net loss (27,207)       (27,207)
Other comprehensive income (loss), net of tax 13     13  
Ending balance (in shares) at Jun. 30, 2025   59,080,630      
Ending balance at Jun. 30, 2025 $ 486,329 $ 59 716,867 396 (230,993)
Beginning balance (in shares) at Dec. 31, 2025 59,101,630 59,101,630      
Beginning balance at Dec. 31, 2025 $ 327,186 $ 59 721,264 629 (394,766)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from the exercise of stock options and settlement of equity awards (in shares)   1,033,432      
Issuance of common stock from the exercise of stock options and settlement of equity awards 0 $ 1 (1)    
Stock-based compensation expense 2,563   2,563    
Net loss (48,567)       (48,567)
Other comprehensive income (loss), net of tax (417)     (417)  
Ending balance (in shares) at Mar. 31, 2026   60,135,062      
Ending balance at Mar. 31, 2026 $ 280,765 $ 60 723,826 212 (443,333)
Beginning balance (in shares) at Dec. 31, 2025 59,101,630 59,101,630      
Beginning balance at Dec. 31, 2025 $ 327,186 $ 59 721,264 629 (394,766)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (111,080)        
Other comprehensive income (loss), net of tax $ (591)        
Ending balance (in shares) at Jun. 30, 2026 60,454,687 60,454,687      
Ending balance at Jun. 30, 2026 $ 220,185 $ 60 725,933 38 (505,846)
Beginning balance (in shares) at Mar. 31, 2026   60,135,062      
Beginning balance at Mar. 31, 2026 280,765 $ 60 723,826 212 (443,333)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from the exercise of stock options and settlement of equity awards (in shares)   319,625      
Stock-based compensation expense 2,107   2,107    
Net loss (62,513)       (62,513)
Other comprehensive income (loss), net of tax $ (174)     (174)  
Ending balance (in shares) at Jun. 30, 2026 60,454,687 60,454,687      
Ending balance at Jun. 30, 2026 $ 220,185 $ 60 $ 725,933 $ 38 $ (505,846)